pediatric subjects
Showing 1 - 25 of >10,000
The ARHINASD Project
Recruiting
- Rhinitis, Allergic
- Data collection
-
Naples, Italy
- +1 more
Nov 22, 2023
Sialorrhea Trial (MYOBLOC Low Dose, MYOBLOC High Dose, Placebo)
Not yet recruiting
- Sialorrhea
- MYOBLOC Low Dose
- +2 more
- (no location specified)
Dec 15, 2022
Adolescent Idiopathic Scoliosis, Juvenile Idiopathic Scoliosis Trial in Sacramento (Methadone, Liposomal bupivacaine (LB,
Recruiting
- Adolescent Idiopathic Scoliosis
- Juvenile Idiopathic Scoliosis
- Methadone
- Liposomal bupivacaine (LB, Exparel)
-
Sacramento, CaliforniaShriners Hospitals for Children
Feb 15, 2023
Methylmalonic Acidemia (MMA) Trial run by the Selecta Biosciences, Inc. (SEL-302)
Recruiting
- Methylmalonic Acidemia (MMA)
-
Bethesda, MarylandNational Human Genome Research Institute, National Institutes of
Mar 9, 2023
Hereditary Angioedema (HAE) Trial (CSL312)
Not yet recruiting
- Hereditary Angioedema (HAE)
- CSL312
- (no location specified)
Apr 17, 2023
Osteogenesis Imperfecta Trial (Bisphosphonate, Setrusumab)
Not yet recruiting
- Osteogenesis Imperfecta
- Bisphosphonate
- Setrusumab
- (no location specified)
Mar 3, 2023
Ulcerative Colitis Trial (Low Dose Budesonide, High Dose Budesonide, Placebo)
Not yet recruiting
- Ulcerative Colitis
- Low Dose Budesonide
- +2 more
- (no location specified)
Sep 7, 2022
Primary Immune Deficiency Trial (Asceniv™)
Recruiting
- Primary Immune Deficiency
- Asceniv™
-
Centennial, Colorado
- +2 more
Sep 13, 2022
Mydriasis, Dilation Trial in Longwood, Athens (Phentolamine Ophthalmic Solution 0.75%, Phentolamine Ophthalmic Solution Vehicle)
Completed
- Mydriasis
- Dilation
- Phentolamine Ophthalmic Solution 0.75%
- Phentolamine Ophthalmic Solution Vehicle
-
Longwood, Florida
- +1 more
Jun 20, 2022
B Precursor Acute Lymphoblastic Leukemia, Relapsed/Refractory B Precursor Acute Lymphoblastic Leukemia Trial (Blinatumomab)
Not yet recruiting
- B Precursor Acute Lymphoblastic Leukemia
- Relapsed/Refractory B Precursor Acute Lymphoblastic Leukemia
- (no location specified)
Sep 25, 2023
Hepatoblastoma, Hepatocellular Carcinoma (HCC), Liver Tumors Trial in Boston (ET140203 T Cells)
Recruiting
- Hepatoblastoma
- +5 more
- ET140203 T Cells
-
Boston, MassachusettsDana-Farber/Boston Children's Cancer and Blood Disorders Center
Aug 12, 2022
Atopic Dermatitis (AD) Trial (0.3% OPA-15406 Ointment, 1% OPA-15406 Ointment, 0% OPA-15406 vehicle)
Not yet recruiting
- Atopic Dermatitis (AD)
- 0.3% OPA-15406 Ointment
- +2 more
- (no location specified)
Jan 28, 2023
CBFA2T3-GLIS2-positive Acute Myeloid Leukemia, AML, Childhood, Relapsed Pediatric AML Trial (ELU001)
Not yet recruiting
- CBFA2T3-GLIS2-positive Acute Myeloid Leukemia
- +3 more
- (no location specified)
Nov 14, 2022
ADHD Trial in Hollywood (Centanafadine)
Completed
- Attention Deficit Hyperactivity Disorder
-
Hollywood, FloridaFor additional information regarding sites, contact 844-687-8522
Jun 1, 2022
Central and Peripheral Wavefront Aberration Profile in Pediatric
Not yet recruiting
- Myopia
- Intervention
-
Houston, TexasUniversity of Houston College of Optometry - J. Armistead Bldg R
Oct 9, 2023
Hypothyroidism Trial in Omaha (Isovue)
Recruiting
- Hypothyroidism
-
Omaha, NebraskaChildren's Hospital and Medical Center
Feb 28, 2022
Brimonidine Tartrate 0.025%/Ketotifen Fumarate 0.035%
Not yet recruiting
- Allergic Conjunctivitis
- rimonidine Tartrate 0.025%/Ketotifen Fumarate 0.035% Ophthalmic Solution (Combo)
- Vehicle of brimonidine tartrate 0.025%/ketotifen fumarate 0.035% ophthalmic solution
- (no location specified)
Apr 4, 2023
Myopia Trial in Kaohsiung City (SHJ - Low concentration, SHJ - Mid concentration, SHJ - High concentration)
Completed
- Myopia
- SHJ - Low concentration
- +3 more
-
Kaohsiung City, TaiwanKaohsiung Veterans General Hospital
Mar 21, 2022